Bando, Y., Hinata, N., Omori, T., & Fujisawa, M. (2019). A prospective, open-label, interventional study protocol to evaluate treatment efficacy of nivolumab based on serum-soluble PD-L1 concentration for patients with metastatic and unresectable renal cell carcinoma. BMJ Open.

Bando, Yukari, Nobuyuki Hinata, Takashi Omori, und Masato Fujisawa. "A Prospective, Open-label, Interventional Study Protocol to Evaluate Treatment Efficacy of Nivolumab Based On Serum-soluble PD-L1 Concentration for Patients With Metastatic and Unresectable Renal Cell Carcinoma." BMJ Open 2019.

Bando, Yukari, Nobuyuki Hinata, Takashi Omori, und Masato Fujisawa. "A Prospective, Open-label, Interventional Study Protocol to Evaluate Treatment Efficacy of Nivolumab Based On Serum-soluble PD-L1 Concentration for Patients With Metastatic and Unresectable Renal Cell Carcinoma." BMJ Open 2019.